Tags

Type your tag names separated by a space and hit enter

Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.

Abstract

The stools of 697 cases were examined by agar plate technique at Tambon Makam Luang, Sun Pa Tong district, Chiang Mai; there were Strongyloides stercoralis 15.9%,Opisthorchis viverrini 5.1%, intestinal fluke 0.1%. Treatment with ivermectin 78 cases and albendazole 33 cases of strongyloidiasis gave cure rates at 98.7% and 78.7%, respectively. Alkaline phosphatase in some patients were increased at mild level after treatment. Side effects in ivermectin group were anorexia, nausia, diarrhea, diffuse itching and drowsiness; and in albendazole group were nausia and diarrhea. The efficacy of single dose and mild side effects suggest ivermectin as drug of choice for strongyloidiasis treatment.

Authors+Show Affiliations

Department of Helminthology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15916052

Citation

Nontasut, Ponganant, et al. "Prevalence of Strongyloides in Northern Thailand and Treatment With Ivermectin Vs Albendazole." The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 36, no. 2, 2005, pp. 442-4.
Nontasut P, Muennoo C, Sa-nguankiat S, et al. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian J Trop Med Public Health. 2005;36(2):442-4.
Nontasut, P., Muennoo, C., Sa-nguankiat, S., Fongsri, S., & Vichit, A. (2005). Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. The Southeast Asian Journal of Tropical Medicine and Public Health, 36(2), 442-4.
Nontasut P, et al. Prevalence of Strongyloides in Northern Thailand and Treatment With Ivermectin Vs Albendazole. Southeast Asian J Trop Med Public Health. 2005;36(2):442-4. PubMed PMID: 15916052.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. AU - Nontasut,Ponganant, AU - Muennoo,Chatree, AU - Sa-nguankiat,Surapol, AU - Fongsri,Sutep, AU - Vichit,Adulsak, PY - 2005/5/27/pubmed PY - 2005/6/25/medline PY - 2005/5/27/entrez SP - 442 EP - 4 JF - The Southeast Asian journal of tropical medicine and public health JO - Southeast Asian J Trop Med Public Health VL - 36 IS - 2 N2 - The stools of 697 cases were examined by agar plate technique at Tambon Makam Luang, Sun Pa Tong district, Chiang Mai; there were Strongyloides stercoralis 15.9%,Opisthorchis viverrini 5.1%, intestinal fluke 0.1%. Treatment with ivermectin 78 cases and albendazole 33 cases of strongyloidiasis gave cure rates at 98.7% and 78.7%, respectively. Alkaline phosphatase in some patients were increased at mild level after treatment. Side effects in ivermectin group were anorexia, nausia, diarrhea, diffuse itching and drowsiness; and in albendazole group were nausia and diarrhea. The efficacy of single dose and mild side effects suggest ivermectin as drug of choice for strongyloidiasis treatment. SN - 0125-1562 UR - https://www.unboundmedicine.com/medline/citation/15916052/Prevalence_of_strongyloides_in_Northern_Thailand_and_treatment_with_ivermectin_vs_albendazole_ DB - PRIME DP - Unbound Medicine ER -